ROCKLAND, Mass.--(BUSINESS WIRE)--May 8, 2006--BioSphere Medical, Inc. (NASDAQ: BSMD - News), a medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization announced today that Richard Faleschini, President and Chief Executive Officer will be presenting an overview of the Company at the Rodman and Renshaw 3rd Annual Global Healthcare Conference in Monte Carlo, Monaco on Monday, May 15, 2006 at 8:40 a.m. Eastern time. The conference is being held at the Le Meridien Beach Plaza Hotel.
